Urachal adenocarcinoma metastatic to the ovaries: case report and literature review. 2003

Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan.

We report a urachal adenocarcinoma metastatic to both ovaries in a 50-year-old Japanese woman. Pelvic examination and imaging studies revealed a large cystic tumor occupying the pelvis and another cystic tumor between the umbilicus and the urinary bladder. A laparotomy was performed. Histopathological examination revealed a urachal tumor that was a well-differentiated invasive mucinous adenocarcinoma; the overlying urothelium was intact. The right and left ovarian tumors were well-differentiated mucinous adenocarcinomas. The urachal and ovarian tumors were immunoreactive for cytokeratin 20 and carcinoembryonic antigen, but negative for cytokeratin 7. The patient is alive with lymph node and bone metastases 6 months postoperatively. This is the eighth reported case of an adenocarcinoma of the bladder with ovarian metastasis.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007381 Intermediate Filament Proteins Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein. Fibroblast Intermediate Filament Proteins,Filament Proteins, Intermediate,Proteins, Intermediate Filament
D007633 Keratins A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION. Cytokeratin,Keratin Associated Protein,Keratin,Keratin-Associated Proteins,alpha-Keratin,Associated Protein, Keratin,Keratin Associated Proteins,Protein, Keratin Associated,alpha Keratin
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002288 Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) Carcinoma, Colloid,Carcinoma, Mucinous,Adenocarcinomas, Mucinous,Carcinomas, Colloid,Carcinomas, Mucinous,Colloid Carcinoma,Colloid Carcinomas,Mucinous Adenocarcinoma,Mucinous Adenocarcinomas,Mucinous Carcinoma,Mucinous Carcinomas
D005260 Female Females

Related Publications

Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
December 2025, Journal of surgical case reports,
Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
September 2023, Indian journal of surgical oncology,
Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
January 2022, Journal of cancer research and therapeutics,
Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
December 2010, International journal of clinical and experimental pathology,
Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
January 1969, Manitoba medical review,
Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
May 2012, Archivos espanoles de urologia,
Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
June 1997, Gynecologic oncology,
Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
September 2025, The Lancet. Infectious diseases,
Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
May 2019, Gynecologic oncology reports,
Satoshi Ohira, and Shigeki Shiohara, and Kazuko Itoh, and Takashi Ashida, and Mana Fukushima, and Ikuo Konishi
May 1982, Neurosurgery,
Copied contents to your clipboard!